54gene’s Clinical Programs Group (CPG)
Phone: +1 310-266-9926; +971 58 594 9926
E-mail: [email protected]
54gene’s Clinical Programs Group (CPG) is a contract research organization that provides innovative, customizable, and cost-effective clinical trials solutions in Africa to global CROs, pharmaceutical companies, medical device companies, academic institutions, research institutions, global health organizations and government institutions.
We provide clinical trial management, regulatory affairs, project management, sample & supply management, laboratory testing, and pharmacovigilance services across multiple disease areas, including genetics-based disorders, infectious diseases, cardiovascular, metabolic & endocrine, oncology, hematology, neurodegenerative, dermatology, immunology and rheumatology, respiratory, sickle cell and other Thalassemia, rare diseases, women’s health, and pediatrics.
We are your one-stop shop for clinical study management and laboratory services. Our laboratories are equipped with world- class equipment and provide analytical testing in multiple disease areas to meet clinical studies sample testing needs. We offer molecular, clinical chemistry, histopathology, hematology, and microbiology lab expertise with high quality and reliable results.
Our experienced native experts, robust sites network, electronic clinical systems, and established research infrastructure on the African continent are leveraged to generate clinical or real evidence data to drive positive research outcomes.
54gene’s CPG is also invested in building clinical research capacity in Africa. We have developed a well- curated electronic clinical research training program to develop local talents offered through our 54gene Clinical Research Academy. 54gene continues to partner with local scientists and researchers to drive scientifically-sound ethical and inclusive clinical research.
- Clinical Trial Management
- Regulatory Affairs
- Project Management
- Sample & Supply Management
- Laboratory Testing
- Pharmaceuticals: Phase I, II, III, & IV studies
- Medical Devices: (non-invasive) feasibility, pivotal and post-market studies
- Diagnostics: clinical utility, reproducibility and post-market studies
- Registry, pharmacovigilance and surveillance studies
54gene is a health technology company tackling the disparity in healthcare research and clinical delivery, with solutions that bridge the gap in precision medicine through large scale discovery and translational research, advanced molecular diagnostics, and clinical programs for the benefit of Africans and the global population.
- Nigeria: 10 Oba Elegushi Beach Road, Lagos
- United States: 1100 15th St. NW, Washington, DC 20005
- United Kingdom: International House 24 Holborn Viaduct London, EC1A 2BN